Genetic Technologies (ASX:GTG) Other Stockholders Equity: A$-0.00 Mil (As of Jun. 2024)


What is Genetic Technologies Other Stockholders Equity?

Genetic Technologies ASX:GTG Other Stockholders Equity is A$-0.00 Mil as of Jun. 2024.

Genetic Technologies's Other Stockholders Equity for the quarter that ended in Jun. 2024 was A$-0.00 Mil.

Genetic Technologies's quarterly Other Stockholders Equity increased from Dec. 2023 (A$-0.00 Mil) to Mar. 2024 (A$0.00 Mil) but then declined from Mar. 2024 (A$0.00 Mil) to Jun. 2024 (A$-0.00 Mil).

Genetic Technologies's annual Other Stockholders Equity increased from Jun. 2022 (A$-0.00 Mil) to Jun. 2023 (A$0.00 Mil) but then declined from Jun. 2023 (A$0.00 Mil) to Jun. 2024 (A$-0.00 Mil).

Genetic Technologies Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Genetic Technologies's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genetic Technologies Other Stockholders Equity Chart

Genetic Technologies Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -0.00 0.00 -0.00

Genetic Technologies Quarterly Data
Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.00 0.00 -0.00 0.00

Genetic Technologies Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of A$-0.00 Mil mean?
Genetic Technologies (ASX:GTG) has a Other Stockholders Equity of A$-0.00 Mil as of Jun. 2024. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Genetic Technologies and its competitors.
Is Genetic Technologies' Other Stockholders Equity too high?
Genetic Technologies' current Other Stockholders Equity is A$-0.00 Mil.
How does Genetic Technologies' Other Stockholders Equity compare to LDDD and NOTV?
Genetic Technologies' Other Stockholders Equity of A$-0.00 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Diagnostics & Research company?
A good Other Stockholders Equity depends on the Medical Diagnostics & Research industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Genetic Technologies and its competitors. Genetic Technologies's current Other Stockholders Equity is A$-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genetic Technologies stock overvalued right now?
Genetic Technologies (ASX:GTG) has a current Other Stockholders Equity of A$-0.00 Mil. The current Other Stockholders Equity is A$-0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Genetic Technologies (ASX:GTG), the current Other Stockholders Equity is A$-0.00 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genetic Technologies Business Description

Address 60-66 Hanover Street, Fitzroy, Melbourne, VIC, AUS, 3065
Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate.